These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9090301)

  • 1. Cholesterol metabolism and tumor cell proliferation.
    Coleman PS; Chen LC; Sepp-Lorenzino L
    Subcell Biochem; 1997; 28():363-435. PubMed ID: 9090301
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular perspective: protein farnesyltransferase.
    Goodsell DS
    Stem Cells; 2004; 22(1):119-20. PubMed ID: 14688398
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol, but not its esters, triggers programmed cell death in human erythroleukemia K562 cells.
    Maccarrone M; Bellincampi L; Melino G; Finazzi Agrò A
    Eur J Biochem; 1998 Apr; 253(1):107-13. PubMed ID: 9578467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein prenylation: unique fats make their mark on biology.
    Wang M; Casey PJ
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):110-22. PubMed ID: 26790532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy.
    Sebti SM
    Cancer Cell; 2005 Apr; 7(4):297-300. PubMed ID: 15837619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of tumor malignancy by inhibitors of posttranslational modification of Ras and Rho family proteins].
    Imoto M
    Seikagaku; 2005 Jun; 77(6):511-8. PubMed ID: 16022427
    [No Abstract]   [Full Text] [Related]  

  • 8. Proximal tubular cholesterol loading after mitochondrial, but not glycolytic, blockade.
    Zager RA; Johnson AC; Hanson SY
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1092-9. PubMed ID: 12952856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins.
    Yu R; Longo J; van Leeuwen JE; Mullen PJ; Ba-Alawi W; Haibe-Kains B; Penn LZ
    Cancer Res; 2018 Mar; 78(5):1347-1357. PubMed ID: 29229608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation.
    Wang IK; Lin-Shiau SY; Lin JK
    Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
    Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y
    Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
    Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
    Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.
    Kohl NE; Mosser SD; deSolms SJ; Giuliani EA; Pompliano DL; Graham SL; Smith RL; Scolnick EM; Oliff A; Gibbs JB
    Science; 1993 Jun; 260(5116):1934-7. PubMed ID: 8316833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anticancer agents move closer to reality.
    Travis J
    Science; 1993 Jun; 260(5116):1877-8. PubMed ID: 8316828
    [No Abstract]   [Full Text] [Related]  

  • 15. Achilles heels and Trojan horses against drug-resistant tumor cells.
    Park K
    J Control Release; 2011 Jan; 149(2):91. PubMed ID: 21167115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlation between inhibitory effect of Manumycin on human hepatoma cancer cell HepG2 and Ras signal transduction pathway].
    Zhou JM; Pan QC; Yang XP; Liu ZC; Liao DF; Fu LW; Liang YJ
    Ai Zheng; 2002 Apr; 21(4):364-8. PubMed ID: 12452012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.
    Ghittoni R; Napolitani G; Benati D; Ulivieri C; Patrussi L; Laghi Pasini F; Lanzavecchia A; Baldari CT
    Eur J Immunol; 2006 Nov; 36(11):2885-93. PubMed ID: 17048274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets.
    Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG
    Nat Rev Drug Discov; 2007 Jul; 6(7):541-55. PubMed ID: 17585331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tiadenol, bis-(hydroxyethylthio)1,10-decane, on cholesterol metabolism in rats.
    Kritchevsky D; Tepper SA; Czarnecki SK; Story JA
    Pharmacol Res Commun; 1979 Nov; 11(10):861-7. PubMed ID: 538065
    [No Abstract]   [Full Text] [Related]  

  • 20. Propiconazole-enhanced hepatic cell proliferation is associated with dysregulation of the cholesterol biosynthesis pathway leading to activation of Erk1/2 through Ras farnesylation.
    Murphy LA; Moore T; Nesnow S
    Toxicol Appl Pharmacol; 2012 Apr; 260(2):146-54. PubMed ID: 22361350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.